EWTX
Edgewise Therapeutics Inc
NASDAQ: EWTX · HEALTHCARE · BIOTECHNOLOGY
$30.45
-1.74% today
Updated 2026-04-29
Market cap
$3.27B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.63
Dividend yield
—
52W range
$12 – $35
Volume
0.9M
Edgewise Therapeutics Inc (EWTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-34.20%
ROA
-23.00%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-9.49M | — | — | — |
| 2020 | $0.00 | $-17.05M | — | — | — |
| 2021 | $0.00 | $-42.14M | — | — | — |
| 2022 | $0.00 | $-15.40M | — | — | — |
| 2023 | $0.00 | $-100.16M | — | — | — |
| 2024 | $0.00 | $-133.81M | — | — | — |
| 2025 | $0.00 | $-167.79M | — | — | — |